Bionow | News

Your Voice Matters: Shape the Future of North East Pharma, HealthTech and Life S...

Oct 25th 2024

To help Square One Law and CPI build an accurate picture of current industry activity, please complete our survey.

Secerna LLP Strengthens Chemistry & Pharmaceutical Team with New Patent Attorney

Oct 14th 2024

Secerna LLP is pleased to announce the addition of Melvyn Ansell to our chemistry & pharmaceutical team. Melvyn brings a wealth of experience and expertise to the firm, further solidifying o...

Cresset appoints new Non-Executive Director

May 21st 2024

Cambridge, 20th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research outcomes, have announced the appointment of Dale ...

Celebrating the North’s world-class manufacturing sector at Pharma Manufacturi...

May 15th 2024

Pharma Manufacturing was once again sold out as we welcomed nearly 200 delegates, exhibitors, and speakers. Industry, academic and regulatory experts came together to collaborate and share t...

Cresset® appoints new Chairman

May 14th 2024

Cambridge, 13th May 2024 – Cresset, innovative provider of computational drug discovery and development solutions that accelerate research outcomes, have announced the appointment of David...

Liverpool City Region’s first Innovation Investment Week to highlight billions...

May 8th 2024

World leading innovation, billions of pounds of opportunities and inspiring the next generation of innovators will be highlighted during Liverpool City Region’s first ever Innovation Inves...

Life Sciences in the North – Join us at Bionow Pharma Manufacturing 2024

Apr 29th 2024

As proud member of the North’s thriving life science community, BioPharma Dynamics are delighted to announce that we’ll be exhibiting again at this year’s Bionow Pharma Manufacturing C...

The importance of brand consistency for life science, healthcare, biotech and ph...

Apr 25th 2024

In an era of heightened competition and consumer expectations, cultivating loyalty and building trust are critical for a brand's success. To establish a consistent brand presence and build t...

Are Free Energy Perturbation (FEP) methods suitable for your project?

Nov 27th 2023

Free Energy Perturbation (FEP) methods are a fast-evolving area of drug discovery, and Cresset Discovery’s dedicated team of expert modelers are establishing a rapidly growing portfolio of...

Driving Optimization of Antibiotic Drug Design

Oct 25th 2023

Since its heyday in the 1950s, the discovery of new classes of antibiotics has decreased, dropping to zero in the 1990s and not recovering since the turn of the century (Figure 1). Worryingl...

September 2023 Newsletter

Oct 2nd 2023

Welcome to the September Cresset Newsletter Optimize your decision-making across the entire design-make-test-analyze (DMTA) cycle with this month's collection of CADD software features, e...

Streamline sharing of CADD data seamlessly to accelerate your drug design proces...

Sep 29th 2023

The globalized outsourcing model of modern drug discovery is driving efficiencies across the Design-Make-Test-Analyze (DMTA) cycle. With projects typically involving multiple specialist CROs...

News